Breaking News, Promotions & Moves

Portola Pharma Names Tao Fu Executive VP

Company is advancing three products in thrombosis and hematologic cancer

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Portola Pharmaceuticals has appointed Tao Fu as executive vice president, chief commercial and business officer. Mr. Fu joins Portola from Bristol-Myers Squibb (BMS), where he was vice president and head of mergers and acquisitions and alliance management. At Portola, Mr. Fu will be responsible for the company’s commercial operations and business development and will serve on the executive committee. “Tao is a proven leader with a track record of success in the biopharmaceutical industry,” sa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters